中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

22 records (took 0.018 seconds)

    Social log file collaboration and annotation
    4.
    发明授权
    Social log file collaboration and annotation 有权
    社交日志文件协作和注释

    公开(公告)号：US09251013B1

    公开(公告)日：2016-02-02

    申请号：US14501148

    申请日：2014-09-30

    Applicant: Sean Walsh ,  Brian Wheeler ,  Jeremy Leng

    Inventor： Sean Walsh ,  Brian Wheeler ,  Jeremy Leng

    IPC: G06F17/30 ,  G06F11/14 ,  G06F11/07

    CPC classification number: G06F11/1471 ,  G06F11/0766 ,  G06F17/30867 ,  G06F17/40 ,  G06F2201/84 ,  G06Q10/06

    Abstract: A system, method, and apparatus of social log file collaboration and annotation is disclosed. In one embodiment, a method identifies a log file of importance, centralizes storage of the log file of importance and generates a social profile of the log file of importance. The method sets an access privilege associated with a user accessing the social profile of the log file of importance and permits the access the social profile of the log file of importance. The method processes a comment and/or an annotation in the social profile of the log file of importance of the user accessing the social profile of the log file of importance using a processor and a memory.

    Abstract translation: 公开了一种社会日志文件协作和注释的系统，方法和装置。 在一个实施例中，一种方法识别重要的日志文件，集中了重要日志文件的存储，并生成重要日志文件的社交简档。 该方法设置与访问重要日志文件的社交简档的用户相关联的访问权限，并允许访问重要日志文件的社交简档。 该方法在用户使用处理器和存储器访问日志文件的社会简档的重要性的重要性的日志文件的社会概况中处理注释和/或注释。

    Database selection system and method to automatically adjust a database schema based on an input data
    5.
    发明授权
    Database selection system and method to automatically adjust a database schema based on an input data 有权
    基于输入数据自动调整数据库模式的数据库选择系统和方法

    公开(公告)号：US09158786B1

    公开(公告)日：2015-10-13

    申请号：US14503415

    申请日：2014-10-01

    Applicant: Sean Walsh ,  Brian Wheeler ,  Jeremy Leng

    Inventor： Sean Walsh ,  Brian Wheeler ,  Jeremy Leng

    IPC: G06F17/30

    CPC classification number: G06F17/30194 ,  G06F17/30292 ,  G06F17/30557

    Abstract: Disclosed are a database selection system and/or a method to automatically adjust a database schema based on an input data. The method of the database selection system includes identifying an attribute of the input data. An optimal database type is determined in which the input data is to be stored based on a match between the optimal database type and the attribute. The method selects an ideal database based on the optimal database type from a set of distributed heterogeneous databases. The method determines if an existing database schema of the ideal database is optimally structured based on the input data. An ideal database schema is automatically adjusted based on the input data using a processor and a memory.

    Abstract translation: 公开了一种基于输入数据自动调整数据库模式的数据库选择系统和/或方法。 数据库选择系统的方法包括识别输入数据的属性。 确定最佳数据库类型，其中基于最佳数据库类型和属性之间的匹配来输入输入数据。 该方法基于一组分布式异构数据库中的最佳数据库类型选择理想数据库。 该方法确定理想数据库的现有数据库模式是否基于输入数据进行最佳结构化。 基于使用处理器和存储器的输入数据自动调整理想的数据库模式。

    Inhibition of C. difficile infections by indigestible oligosaccharides
    8.
    发明授权
    Inhibition of C. difficile infections by indigestible oligosaccharides 失效
    通过难消化的寡糖抑制艰难梭菌感染

    公开(公告)号：US5688777A

    公开(公告)日：1997-11-18

    申请号：US417413

    申请日：1995-04-05

    Applicant: Keith Allen Garleb ,  Bryan Warren Wolf ,  Jonathan Allan Meulbroek ,  Keith Brian Wheeler

    Inventor： Keith Allen Garleb ,  Bryan Warren Wolf ,  Jonathan Allan Meulbroek ,  Keith Brian Wheeler

    IPC: A61K33/14 ,  A01N43/04

    CPC classification number: A61K31/7016 ,  A61K31/702 ,  A61K33/14

    Abstract: The primary etiology of antibiotic-associated diarrhea (which may lead to pseudomembranous colitis) has been recognized as Clostridium difficile. It is believed that the indigenous microflora of a healthy individual suppresses the normally present C. difficile. However, when the indigenous microflora are disrupted (e.g., during antibiotic treatment) overgrowth of C. difficile may occur causing diarrhea and colitis. Treatment of C. difficile with antibiotics has proven effective, but many times relapse occurs. The present invention involves a non-antibiotic approach to the treatment and/or prevention of C. difficile--associated diseases. A therapeutically effective amount of an indigestible oligosaccharide inhibits the infection of mammals by C. difficile when administered enterally.

    Abstract translation: 抗生素相关性腹泻（可能导致假膜性结肠炎）的主要病因已被认为是艰难梭菌。 据信，健康个体的土着微生物群落抑制了正常存在的艰难梭菌。 然而，当土着微生物群落被破坏时（例如，在抗生素处理期间），可能会发生艰难梭菌的过度生长，导致腹泻和结肠炎。 用抗生素治疗艰难梭菌已被证明是有效的，但是很多时候发生复发。 本发明涉及治疗和/或预防艰难梭菌相关疾病的非抗生素方法。 消化不良的寡糖的治疗有效量在肠内施用时抑制艰难梭菌感染哺乳动物。

Patent Agency Ranking